BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 20849438)

  • 1. Clinical interpretation of Fibroscan® results: a real challenge.
    Boursier J; Calès P
    Liver Int; 2010 Nov; 30(10):1400-2. PubMed ID: 20849438
    [No Abstract]   [Full Text] [Related]  

  • 2. Prevalence, risk factors and causes of discordance in fibrosis staging by transient elastography and liver biopsy.
    Myers RP; Crotty P; Pomier-Layrargues G; Ma M; Urbanski SJ; Elkashab M
    Liver Int; 2010 Nov; 30(10):1471-80. PubMed ID: 20807336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Value of FibroScan in clinical diagnosis].
    Nie JJ; Li J; Zhuang H
    Zhonghua Gan Zang Bing Za Zhi; 2009 Sep; 17(9):715-7. PubMed ID: 19785970
    [No Abstract]   [Full Text] [Related]  

  • 4. [Transient elastography, true or false?].
    Seo YS
    Korean J Hepatol; 2009 Dec; 15(4):431-7. PubMed ID: 20037261
    [No Abstract]   [Full Text] [Related]  

  • 5. The usefulness of measuring liver stiffness by transient elastography for assessing hepatic fibrosis in patients with various chronic liver diseases.
    Tamano M; Kojima K; Akima T; Murohisa T; Hashimoto T; Uetake C; Sugaya T; Nakano M; Hiraishi H; Yoneda M
    Hepatogastroenterology; 2012 May; 59(115):826-30. PubMed ID: 22469726
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved fibrosis staging by elastometry and blood test in chronic hepatitis C.
    Calès P; Boursier J; Ducancelle A; Oberti F; Hubert I; Hunault G; de Lédinghen V; Zarski JP; Salmon D; Lunel F;
    Liver Int; 2014 Jul; 34(6):907-17. PubMed ID: 24102852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of Fibroscan on management of chronic viral hepatitis in clinical practice.
    Fransen van de Putte D; Blom R; van Soest H; Mundt M; Verveer C; Arends J; de Knegt RE; Mauser-Bunschoten E; van Erpecum K
    Ann Hepatol; 2011; 10(4):469-76. PubMed ID: 21911887
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-invasive assessment of liver fibrosis: the gap between ideal and real.
    Kim SU; Han KH; Ahn SH
    J Gastroenterol Hepatol; 2011 Jun; 26(6):937-9. PubMed ID: 21564284
    [No Abstract]   [Full Text] [Related]  

  • 9. Serum aminotransferase levels instead of etiology affects the accuracy of transient elastography in chronic viral hepatitis patients.
    Cho HJ; Seo YS; Lee KG; Hyun JJ; An H; Keum B; Kim JH; Yim HJ; Jeen YT; Lee HS; Chun HJ; Um SH; Kim CD; Ryu HS
    J Gastroenterol Hepatol; 2011 Mar; 26(3):492-500. PubMed ID: 21332545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical application of transient elastography in patients with chronic viral hepatitis receiving antiviral treatment.
    Kim JH; Kim MN; Han KH; Kim SU
    Liver Int; 2015 Apr; 35(4):1103-15. PubMed ID: 24976523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reliability of transient elastography for the detection of fibrosis in non-alcoholic fatty liver disease and chronic viral hepatitis.
    Gaia S; Carenzi S; Barilli AL; Bugianesi E; Smedile A; Brunello F; Marzano A; Rizzetto M
    J Hepatol; 2011 Jan; 54(1):64-71. PubMed ID: 20932598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Noninvasive assessment of liver fibrosis.
    Martínez SM; Crespo G; Navasa M; Forns X
    Hepatology; 2011 Jan; 53(1):325-35. PubMed ID: 21254180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-invasive assessment of fibrosis in non-alcoholic fatty liver disease.
    Vizzutti F; Arena U; Nobili V; Tarquini R; Trappoliere M; Laffi G; Marra F; Pinzani M
    Ann Hepatol; 2009; 8(2):89-94. PubMed ID: 19502649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Noninvasive methods to assess liver disease in patients with hepatitis B or C.
    Castera L
    Gastroenterology; 2012 May; 142(6):1293-1302.e4. PubMed ID: 22537436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Transient elastography].
    Della Valle S; Branchi F; Rigamonti C; Fraquelli M
    Recenti Prog Med; 2009 Apr; 100(4):195-201. PubMed ID: 19554919
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-invasive assessment of liver fibrosis: time to move from cross-sectional studies to longitudinal ones.
    Kim SU; Han KH; Ahn SH
    J Gastroenterol Hepatol; 2010 Sep; 25(9):1472-3. PubMed ID: 20796140
    [No Abstract]   [Full Text] [Related]  

  • 17. Assessment of inflammation and fibrosis in non-alcoholic fatty liver disease by imaging-based techniques.
    Cobbold JF; Patel D; Taylor-Robinson SD
    J Gastroenterol Hepatol; 2012 Aug; 27(8):1281-92. PubMed ID: 22432836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-invasive evaluation of liver fibrosis in chronic hepatitis C.
    Trifan A; Cojocariu C; Sfarti C; Singeap AM; Stanciu C
    Rev Med Chir Soc Med Nat Iasi; 2012; 116(1):135-8. PubMed ID: 23077885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationships between fibrosis amounts assessed by morphometry and liver stiffness measurements in chronic hepatitis or steatohepatitis.
    Ziol M; Kettaneh A; Ganne-Carrié N; Barget N; Tengher-Barna I; Beaugrand M
    Eur J Gastroenterol Hepatol; 2009 Nov; 21(11):1261-8. PubMed ID: 19478678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic accuracy of FibroScan and comparison to liver fibrosis biomarkers in chronic viral hepatitis: a multicenter prospective study (the FIBROSTIC study).
    Degos F; Perez P; Roche B; Mahmoudi A; Asselineau J; Voitot H; Bedossa P;
    J Hepatol; 2010 Dec; 53(6):1013-21. PubMed ID: 20850886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.